Berkeley Lab statistician Paul Williams seeks to explain how genetics and external factors interact to shape alcohol consumption, lung function, and weight gain – aspects of health that are on many of our minds during the the coronavirus pandemic and wildfires.
Berkeley Lab bioscientists are part of a nationwide research project, called ENCODE, that has generated a detailed atlas of the molecular elements that regulate our genes. This enormous resource will help all human biology research moving forward.
Our biomanufacturing experts are helping accelerate the development of new COVID-19-fighting technologies. Learn how the scientists at the ABPDU are collaborating with biotech companies to scale up and optimize production of coronavirus-targeting antibodies and a highly accurate rapid testing system.
Even an underground experiment 4,600 feet below a mountain in Central Italy, and a telescope instrument more than a mile high atop an Arizona mountaintop could not escape the impacts of the COVID-19 pandemic. In these videos, a Berkeley Lab scientist and two Berkeley Lab-affiliated researchers share their experiences of working in international collaborations during the COVID-19 pandemic.
Sometimes, when something is broken, the first step to fixing it is to break it even more. Scientists have discovered this is the case for a human DNA repair protein that functions by marking and then further breaking damaged DNA. Their surprising findings have provided much-needed insight into how DNA repair works in healthy cells, as well as how different mutations can translate into different diseases and cancer.
One of the many unanswered scientific questions about COVID-19 is whether it is seasonal like the flu – waning in warm summer months then resurging in the fall and winter. Now scientists at Lawrence Berkeley National Laboratory are launching a project to apply machine-learning methods to a plethora of health and environmental datasets, combined with high-resolution climate models and seasonal forecasts, to tease out the answer.
An international scientific team has discovered a neutralizing antibody, derived from the blood of a SARS survivor, that inhibits the closely related COVID-19-causing coronavirus. In a paper published this week in Nature, the scientists note that the antibody is already on an accelerated development path toward clinical trials.
As society prepares to reopen indoor spaces and ease back into some sense of normalcy during the COVID-19 pandemic, a team of researchers at Berkeley Lab is launching a study of the risk of airborne transmission of viruses within buildings and how to mitigate those risks.
Scientists from Pacific Northwest and Lawrence Berkeley National Laboratories showed that both dietary and supplementary sources of a common gut microbe or its main chemical product, lactic acid, led to better memory performance in mice.
Berkeley Lab’s Advanced Light Source X-ray facility has been recalled to action to support research related to COVID-19, the coronavirus disease that has already infected about 2 million people around the world.